IMPACT STUDY: Investigating Microbial Pathogen Activity of Copper Textiles
This trial is active, not recruiting.
|Treatment||copper linen exposure|
|Sponsor||University of Pennsylvania|
|Collaborator||Centers for Disease Control and Prevention|
|Start date||January 2016|
|End date||May 2017|
|Trial size||424 participants|
|Trial identifier||NCT02627092, 822418|
The purpose of this study is to assess the impact of copper linens on hospital acquired infections and drug resistant bacteria.
|United States||No locations recruiting|
|Other countries||No locations recruiting|
|Intervention model||parallel assignment|
Assessment of intensive care -related hospital-acquired infections or multi-drug resistant organisms
time frame: Duration of ICU (must be >48 hours) stay plus 2 additional hospital days
All participants at least 18 years old.
- Hospital inpatients
- Admission to intensive care unit
- Hospital Admission at least 48 hours
- Hospital admission less than 48 hours
|Official title||An Innovative Approach to Understanding and Controlling Transmission of HAIs|
|Principal investigator||Ebbing Lautenbach, MD,MPH,MSCE|
|Description||Healthcare-associated infections (HAIs), particularly those due to multidrug-resistant organisms (MDROs), are of great clinical and public health concern. Although evidence-based prevention strategies have resulted in some success in curtailing HAIs, novel approaches are needed to achieve further reductions. Efforts to curb the emergence of MDROs have been largely unsuccessful. Thus, new strategies to address MDROs are urgently needed. This grant is comprised of two complementary studies that focus on identifying innovative approaches to more effectively prevent HAIs and curtail further emergence of MDROs. We will conduct a randomized controlled trial (RCT) to assess the efficacy of copper oxide-impregnated textiles in preventing HAIs and MDROs as well as in reducing environmental microbial contamination. We hope to provide critical information to inform the development of novel strategies, and enhance the impact of existing strategies, to successfully address HAIs and MDROs. For approximately four months the hospital is conducting a research study to learn about the possible impact of copper linens in reducing hospital acquired infections. Some rooms will have copper linens (Group 1) and some rooms will have regular linens (Group 2). The linens will be comprised of the top and bottom sheets, pillowcase cover, and hospital gown. Patients in both groups will be asked to provide samples during their stay in the ICU. For both study groups, the linens will be sampled twice after they are placed. This will occur on 2 consecutive days. At the same time, study staff will take samples from several areas of the room (the hand rails, overbed table, nurse call button). Patients will also be asked to allow the research team to obtain swabs of the nose, per-rectal area, armpit and groin. These swabs will be performed on their first day enrolled into the study, then 4 days later, and every week until ICU discharge.|
Call for more information